|
|
.
NPI Detail
NPI: 1285641514
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
270-05 76 XXX
NEW HYDE PARK, NY 11040
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1285641514*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 85027
|
COMPLETE CBC AUTOMATED
|
XXXXX
|
$XXXXX.XX
|
| 36416
|
COLLJ CAPILLARY BLOOD SPEC
|
XXXXX
|
-
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J7183
|
Wilate injection
|
XXXXXXX
|
$XXXXXXX.XX
|
| J7192
|
Factor viii recombinant nos
|
XXXXXXX
|
$XXXXXXX.XX
|
| J7190
|
Factor viii
|
XXXXXX
|
$XXXXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J7201
|
Factor ix alprolix recomb
|
XXXXXX
|
$XXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
| J1453
|
Fosaprepitant injection
|
XXXXXX
|
$XXXXX.XX
|
| J7193
|
Factor ix non-recombinant
|
XXXXXX
|
-
|
| J9263
|
Oxaliplatin
|
XXXXXX
|
-
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXXXX
|
-
|
| J1642
|
Inj heparin sodium per 10 u
|
XXXXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXXX
|
$XXXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J7195
|
Factor ix recombinant nos
|
XXXXX
|
$XXXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXXX.XX
|
| J9022
|
Inj, atezolizumab,10 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXX
|
-
|
| J2469
|
Palonosetron hcl
|
XXXXX
|
-
|
| J9305
|
Inj. pemetrexed nos 10mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9177
|
Inj enfort vedo-ejfv 0.25mg
|
XXXXX
|
$XXXXXX.XX
|
| J9349
|
Inj., tafasitamab-cxix
|
XXXXX
|
$XXXXXX.XX
|
| J1569
|
Gammagard liquid injection
|
XXXXX
|
$XXXXXX.XX
|
| J9119
|
Inj., cemiplimab-rwlc, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J9041
|
Injection, bortezomib, 0.1mg
|
XXXXX
|
$XXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXX
|
$XXXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
